A Novel Orf Virus D1701-VrV-Based Dengue Virus (DENV) Vaccine Candidate Expressing HLA-Specific T Cell Epitopes: A Proof-of-Concept Study

Although dengue virus (DENV) affects almost half of the world’s population there are neither preventive treatments nor any long-lasting and protective vaccines available at this time. The complexity of the protective immune response to DENV is still not fully understood. The most advanced vaccine ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Reguzova, Alena, Fischer, Nico, Müller, Melanie, Salomon, Ferdinand, Jaenisch, Thomas, Amann, Ralf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698572/
https://www.ncbi.nlm.nih.gov/pubmed/34944678
http://dx.doi.org/10.3390/biomedicines9121862

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698572/
https://www.ncbi.nlm.nih.gov/pubmed/34944678
http://dx.doi.org/10.3390/biomedicines9121862

Ejemplares similares